Leukoapheresis in Crohn's disease: the final curtain?
Inserm U954 and Department of Hepato-Gastroenterology, University Hospital of Nancy-Brabois, Allée du Morvan, Vandoeuvre-lès-Nancy 54511, France. peyrinbiroulet@gmail.com
Laurent
L
Peyrin-Biroulet
Silvio
S
Danese
D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy / Q000628:therapy*; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D000069285:Infliximab; D007937:Leukapheresis / Q000295:instrumentation / Q000379:methods*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D005765:Gastrointestinal Agents; D000069285:Infliximab; D000068879:Adalimumab